• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

海洋无脊椎动物的生物材料和生物活性天然产物:从基础研究到创新应用。

Biomaterials and Bioactive Natural Products from Marine Invertebrates: From Basic Research to Innovative Applications.

机构信息

Marine Biotechnology Department, Stazione Zoologica Anton Dohrn, Villa Comunale, 80121 Naples, Italy.

3B's Research Group, I3B's-Research Institute on Biomaterials, Biodegradables and Biomimetics of University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark-Parque de Ciência e Tecnologia, Barco, 4805-017 Guimarães, Portugal.

出版信息

Mar Drugs. 2022 Mar 22;20(4):219. doi: 10.3390/md20040219.

DOI:10.3390/md20040219
PMID:35447892
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9027906/
Abstract

Aquatic invertebrates are a major source of biomaterials and bioactive natural products that can find applications as pharmaceutics, nutraceutics, cosmetics, antibiotics, antifouling products and biomaterials. Symbiotic microorganisms are often the real producers of many secondary metabolites initially isolated from marine invertebrates; however, a certain number of them are actually synthesized by the macro-organisms. In this review, we analysed the literature of the years 2010-2019 on natural products (bioactive molecules and biomaterials) from the main phyla of marine invertebrates explored so far, including sponges, cnidarians, molluscs, echinoderms and ascidians, and present relevant examples of natural products of interest to public and private stakeholders. We also describe omics tools that have been more relevant in identifying and understanding mechanisms and processes underlying the biosynthesis of secondary metabolites in marine invertebrates. Since there is increasing attention on finding new solutions for a sustainable large-scale supply of bioactive compounds, we propose that a possible improvement in the biodiscovery pipeline might also come from the study and utilization of aquatic invertebrate stem cells.

摘要

水生无脊椎动物是生物材料和生物活性天然产物的主要来源,可作为药物、营养保健品、化妆品、抗生素、防污产品和生物材料应用。共生微生物通常是最初从海洋无脊椎动物中分离出来的许多次生代谢物的真正生产者;然而,其中有一定数量的次生代谢物实际上是由大型生物合成的。在这篇综述中,我们分析了 2010 年至 2019 年的文献,这些文献涉及迄今为止探索的海洋无脊椎动物的主要门(海绵动物、刺胞动物、软体动物、棘皮动物和尾索动物)中的天然产物(生物活性分子和生物材料),并介绍了相关的天然产物实例,这些产物对公共和私营利益相关者都具有重要意义。我们还描述了在鉴定和理解海洋无脊椎动物次生代谢物生物合成的机制和过程方面更相关的组学工具。由于人们越来越关注寻找新的解决方案来实现生物活性化合物的可持续大规模供应,我们提出,水生无脊椎动物干细胞的研究和利用也可能改善生物发现的途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f85/9027906/6808f69419b1/marinedrugs-20-00219-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f85/9027906/af1e6826486c/marinedrugs-20-00219-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f85/9027906/3968277c6fc7/marinedrugs-20-00219-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f85/9027906/a426b5bf7288/marinedrugs-20-00219-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f85/9027906/4e3c7f9d92f9/marinedrugs-20-00219-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f85/9027906/453b90795637/marinedrugs-20-00219-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f85/9027906/4d04a692863b/marinedrugs-20-00219-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f85/9027906/42f7607845e6/marinedrugs-20-00219-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f85/9027906/026d83e6b999/marinedrugs-20-00219-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f85/9027906/5a2a7f7197cd/marinedrugs-20-00219-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f85/9027906/a6c81d25f339/marinedrugs-20-00219-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f85/9027906/5c9de57f8805/marinedrugs-20-00219-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f85/9027906/2a4d1e8aab81/marinedrugs-20-00219-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f85/9027906/9de0b4ea99bb/marinedrugs-20-00219-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f85/9027906/4409c3176503/marinedrugs-20-00219-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f85/9027906/def995a26991/marinedrugs-20-00219-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f85/9027906/af004fa9609e/marinedrugs-20-00219-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f85/9027906/e47eeb4c6b2b/marinedrugs-20-00219-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f85/9027906/e682dc228645/marinedrugs-20-00219-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f85/9027906/7d90d0a637ec/marinedrugs-20-00219-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f85/9027906/6808f69419b1/marinedrugs-20-00219-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f85/9027906/af1e6826486c/marinedrugs-20-00219-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f85/9027906/3968277c6fc7/marinedrugs-20-00219-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f85/9027906/a426b5bf7288/marinedrugs-20-00219-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f85/9027906/4e3c7f9d92f9/marinedrugs-20-00219-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f85/9027906/453b90795637/marinedrugs-20-00219-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f85/9027906/4d04a692863b/marinedrugs-20-00219-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f85/9027906/42f7607845e6/marinedrugs-20-00219-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f85/9027906/026d83e6b999/marinedrugs-20-00219-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f85/9027906/5a2a7f7197cd/marinedrugs-20-00219-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f85/9027906/a6c81d25f339/marinedrugs-20-00219-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f85/9027906/5c9de57f8805/marinedrugs-20-00219-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f85/9027906/2a4d1e8aab81/marinedrugs-20-00219-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f85/9027906/9de0b4ea99bb/marinedrugs-20-00219-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f85/9027906/4409c3176503/marinedrugs-20-00219-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f85/9027906/def995a26991/marinedrugs-20-00219-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f85/9027906/af004fa9609e/marinedrugs-20-00219-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f85/9027906/e47eeb4c6b2b/marinedrugs-20-00219-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f85/9027906/e682dc228645/marinedrugs-20-00219-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f85/9027906/7d90d0a637ec/marinedrugs-20-00219-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f85/9027906/6808f69419b1/marinedrugs-20-00219-g020.jpg

相似文献

1
Biomaterials and Bioactive Natural Products from Marine Invertebrates: From Basic Research to Innovative Applications.海洋无脊椎动物的生物材料和生物活性天然产物:从基础研究到创新应用。
Mar Drugs. 2022 Mar 22;20(4):219. doi: 10.3390/md20040219.
2
Highlights of marine invertebrate-derived biosynthetic products: their biomedical potential and possible production by microbial associants.海洋无脊椎动物生物合成产物的亮点:它们的医学潜力及其通过微生物共生体可能的生产。
Bioorg Med Chem. 2011 Nov 15;19(22):6658-74. doi: 10.1016/j.bmc.2011.07.017. Epub 2011 Jul 26.
3
Bioactive Molecules from the Innate Immunity of Ascidians and Innovative Methods of Drug Discovery: A Computational Approach Based on Artificial Intelligence.来自海鞘先天免疫的生物活性分子与创新药物发现方法:基于人工智能的计算方法
Mar Drugs. 2023 Dec 20;22(1):6. doi: 10.3390/md22010006.
4
Bioactive Aliphatic Sulfates from Marine Invertebrates.海洋无脊椎动物中的生物活性脂肪族硫酸盐。
Mar Drugs. 2019 Sep 9;17(9):527. doi: 10.3390/md17090527.
5
Marine Invertebrate Metabolites with Anticancer Activities: Solutions to the "Supply Problem".具有抗癌活性的海洋无脊椎动物代谢产物:“供应问题”的解决方案
Mar Drugs. 2016 May 21;14(5):98. doi: 10.3390/md14050098.
6
Aquaculture of "non-food organisms" for natural substance production.用于天然物质生产的“非食用生物”的水产养殖。
Adv Biochem Eng Biotechnol. 2005;97:1-28.
7
Statistical research on marine natural products based on data obtained between 1985 and 2008.基于 1985 年至 2008 年期间获得的数据对海洋天然产物进行的统计研究。
Mar Drugs. 2011;9(4):514-525. doi: 10.3390/md9040514. Epub 2011 Mar 29.
8
Antimycobacterial Metabolites from Marine Invertebrates.来自海洋无脊椎动物的抗分枝杆菌代谢产物。
Arch Pharm (Weinheim). 2016 Oct;349(10):763-773. doi: 10.1002/ardp.201600128. Epub 2016 Aug 26.
9
Marine-Inspired Drugs and Biomaterials in the Perspective of Pancreatic Cancer Therapies.海洋启发药物和生物材料在胰腺癌治疗中的应用
Mar Drugs. 2022 Nov 1;20(11):689. doi: 10.3390/md20110689.
10
Marine natural products.海洋天然产物。
Nat Prod Rep. 2018 Jan 16;35(1):8-53. doi: 10.1039/c7np00052a.

引用本文的文献

1
Fabrication and characterization of electrospun polycaprolactone/ derived-ECM composite scaffolds for small-diameter vascular grafts.用于小口径血管移植物的电纺聚己内酯/衍生细胞外基质复合支架的制备与表征
RSC Adv. 2025 Aug 29;15(38):31060-31075. doi: 10.1039/d5ra04406e.
2
Nudibranchs as Sources of Marine Natural Products with Antitumor Activity: A Comprehensive Review.裸鳃亚目动物作为具有抗肿瘤活性的海洋天然产物来源:综述
Mar Drugs. 2025 Aug 3;23(8):319. doi: 10.3390/md23080319.
3
Immunomodulatory Effects of Protamine and Its PEG Derivative on Macrophages: Involvement of PI3K/Akt Signaling, Redox Regulation, and Cell Cycle Modulation.

本文引用的文献

1
Arrested in Glass: Actin within Sophisticated Architectures of Biosilica in Sponges.被困在玻璃中:海绵生物硅石中复杂结构内的肌动蛋白。
Adv Sci (Weinh). 2022 Apr;9(11):e2105059. doi: 10.1002/advs.202105059. Epub 2022 Feb 13.
2
From Life in the Sea to the Clinic: The Marine Drugs Approved and under Clinical Trial.从海洋生物到临床应用:已批准及正在临床试验的海洋药物
Life (Basel). 2021 Dec 11;11(12):1390. doi: 10.3390/life11121390.
3
Genome mining methods to discover bioactive natural products.基因组挖掘方法发现生物活性天然产物。
鱼精蛋白及其聚乙二醇衍生物对巨噬细胞的免疫调节作用:PI3K/Akt信号传导、氧化还原调节和细胞周期调控的参与
Antioxidants (Basel). 2025 Apr 4;14(4):437. doi: 10.3390/antiox14040437.
4
Advancing marine invertebrate cell line research: four key knowledge gaps.推进海洋无脊椎动物细胞系研究:四个关键知识空白。
In Vitro Cell Dev Biol Anim. 2025 Mar 28. doi: 10.1007/s11626-025-01029-y.
5
Diterpenoids of Marine Organisms: Isolation, Structures, and Bioactivities.海洋生物的二萜类化合物:分离、结构与生物活性
Mar Drugs. 2025 Mar 18;23(3):131. doi: 10.3390/md23030131.
6
On Oscillations in the External Electrical Potential of Sea Urchins.关于海胆外部电势的振荡
ACS Omega. 2025 Jan 8;10(2):2327-2337. doi: 10.1021/acsomega.4c10277. eCollection 2025 Jan 21.
7
Antimicrobial proteins from oyster hemolymph improve the efficacy of conventional antibiotics.来自牡蛎血淋巴的抗菌蛋白可提高传统抗生素的疗效。
PLoS One. 2025 Jan 21;20(1):e0312305. doi: 10.1371/journal.pone.0312305. eCollection 2025.
8
Synthesis and Anticancer Activity Assessment of Zelkovamycin Analogues.泽拉霉素类似物的合成及抗癌活性评估。
Molecules. 2024 Sep 21;29(18):4483. doi: 10.3390/molecules29184483.
9
Stichoposide C and Rhizochalin as Potential Aquaglyceroporin Modulators.毛蕊花糖苷 C 和 Rhizochalin 作为潜在的水通道蛋白调节剂。
Mar Drugs. 2024 Jul 25;22(8):335. doi: 10.3390/md22080335.
10
The Promising Potential of in Dermatology.[具体内容]在皮肤科的广阔前景。 (你提供的原文不完整,缺少关键信息,这里只能补充完整格式,具体翻译需你补充完整原文后进行)
Curr Issues Mol Biol. 2024 Jul 18;46(7):7619-7620. doi: 10.3390/cimb46070452.
Nat Prod Rep. 2021 Nov 17;38(11):2100-2129. doi: 10.1039/d1np00032b.
4
3-D Culture of Marine Sponge Cells for Production of Bioactive Compounds.海洋海绵细胞的 3-D 培养用于生产生物活性化合物。
Mar Drugs. 2021 Oct 14;19(10):569. doi: 10.3390/md19100569.
5
Mining and unearthing hidden biosynthetic potential.挖掘和发掘隐藏的生物合成潜力。
Nat Commun. 2021 Jun 23;12(1):3864. doi: 10.1038/s41467-021-24133-5.
6
Fucoidan from brown algae Fucus evanescens potentiates the anti-proliferative efficacy of asterosaponins from starfish Asteropsis carinifera in 2D and 3D models of melanoma cells.来自囊藻 Fucus evanescens 的褐藻岩藻聚糖增强了海星 Asteropsis carinifera 的甾族皂甙在黑素瘤细胞的 2D 和 3D 模型中的抗增殖作用。
Int J Biol Macromol. 2021 Aug 31;185:31-39. doi: 10.1016/j.ijbiomac.2021.06.080. Epub 2021 Jun 16.
7
Marine Natural Products from Tunicates and Their Associated Microbes.海洋被囊动物及其共生微生物来源的天然产物。
Mar Drugs. 2021 May 26;19(6):308. doi: 10.3390/md19060308.
8
A Prototype Skin Substitute, Made of Recycled Marine Collagen, Improves the Skin Regeneration of Sheep.一种由回收海洋胶原蛋白制成的皮肤替代物原型,可促进绵羊皮肤再生。
Animals (Basel). 2021 Apr 23;11(5):1219. doi: 10.3390/ani11051219.
9
Diverse and Productive Source of Biopolymer Inspiration: Marine Collagens.海洋胶原蛋白:生物聚合物灵感的多样且丰富来源。
Biomacromolecules. 2021 May 10;22(5):1815-1834. doi: 10.1021/acs.biomac.1c00013. Epub 2021 Apr 9.
10
Natural products in drug discovery: advances and opportunities.天然产物在药物发现中的应用:进展与机遇。
Nat Rev Drug Discov. 2021 Mar;20(3):200-216. doi: 10.1038/s41573-020-00114-z. Epub 2021 Jan 28.